Actively Recruiting
Feasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid
Led by University of Calgary · Updated on 2026-05-14
220
Participants Needed
2
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
University of Calgary
Lead Sponsor
U
University of Alberta
Collaborating Sponsor
AI-Summary
What this Trial Is About
Many people with kidney disease also have heart disease. The procedures used to diagnose and treat heart disease (e.g., angiograms, angioplasty, or surgery) can improve symptoms and cardiovascular outcomes, but pose greater risks of kidney complications for people with chronic kidney disease. It's therefore important that patients with kidney disease and their health care providers understand the benefits versus risks of these procedures and use that information to make informed decisions regarding their health care. Prior research done with patients with kidney disease and their health care providers has led to the develop of a decision aid designed to help doctors provide personalized information on the benefits versus risks of having a heart procedure, as well as help patients communicate their own values and preferences to their doctor. This information is crucial for shared decision making, as previous research has shown that preferences and values vary for individual patients with kidney diseases, and should be incorporated into the decision-making process for heart disease management. The decision aid, called "My Heart Care and CKD", supports shared decision-making between patients with kidney disease and heart their care providers. This trial will implement and evaluate this decision aid within cardiovascular care in a pilot trial in Canada.
CONDITIONS
Official Title
Feasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (18 years of age or older)
- Diagnosed with chronic kidney disease
- Diagnosed with coronary artery disease, including non-ST elevation acute coronary syndrome or symptoms/signs of stable coronary heart disease
- Able to communicate in English or French, or through a support person who speaks English or French
- Has cognitive ability or a surrogate decision maker capable of shared decision making as determined by the attending physician
You will not qualify if you...
- End stage kidney failure treated with dialysis or with eGFR less than 10 mL/min/1.73 m2
- ST-elevation myocardial infarction
- Not expected to survive until hospital discharge
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9
Actively Recruiting
2
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 0M9
Actively Recruiting
Research Team
P
Pantea Javaheri, MRSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here